Category: Bone-Conduction Solutions

Bone-Conduction Solutions

Latest

Oticon Neuro System Receives FDA Premarket Approval

Oticon Medical announced that the US Food and Drug Administration (FDA) has granted premarket approval (PMA) to the company’s Neuro System to treat individuals 18 years or older, with bilateral severe-to-profound sensorineural hearing loss, who obtain limited benefit from appropriately fitted hearing aid(s).

Managing People with Sensorineural and Conductive Unilateral Hearing Loss and Single-Sided Deafness

CROS and BiCROS hearing aids are not the only treatment options for those with unilateral hearing loss. This article reviews other options and potential future avenues for unilateral sensorineural hearing loss and single-sided deafness, as well as for unilateral conductive hearing loss.

Read More

Deaf Children with Implants Since Infancy More Likely to Speak

Researchers from Ann & Robert H. Lurie Children’s Hospital of Chicago present further evidence that deaf children who received cochlear implants (implanted electronic hearing device) before 12 months of age learn to more rapidly understand spoken language and are more likely to develop spoken language as their exclusive form of communication.

Read More
Loading